No NHI reimbursable for unauthorized indications.

Published: 2002-03-14 07:00:00

Updated: 2002-03-14 07:00:00

In line with an NHI financial stabilization measure the MOHW is going to reject the NHI reimbursement for the medication for unauthorized indications, taking effect from coming April.

So far the government restrained the reimbursement rejection against medications for other indications than th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK